Artificial intelligence (AI) is revolutionising the field of drug discovery and development, according to a new academic paper titled “Artificial Intelligence in Pharmaceutical Sciences.” The paper highlights the advantages of AI in all aspects of new drug research and development, including target discovery, drug design, preclinical research, clinical trial design, and post-market surveillance. AI enables more efficient and cost-effective drug discovery by analysing vast amounts of biomedical data. While some limitations still exist, the authors emphasise that AI is an indispensable technology in the drug R&D process, significantly reducing cycle time and costs. They believe that AI will continue to shape the pharmaceutical industry, providing personalised medicine and unlocking the mysteries of complex biological systems. The authors call for further research to harness the full potential of AI in drug development.